Login to Your Account

Financings Roundup

Thursday, March 24, 2011
• Sanofi-Aventis SA, of Paris, priced an offering of $7 billion of notes, consisting of six tranches, pursuant to its shelf registration statement. Sanofi will use net proceeds to fund, in part, the consideration payable for its $21.2 billion acquisition of Cambridge, Mass.-based Genzyme Corp. and related costs. (See BioWorld Today, Feb. 7, 2011.)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription